← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $3.3M of Intra-Cellular Therapies, Inc.

Sold$3,251,087
$58.79Price
55,300Shares
−55%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Mon, Aug 7. Filed Wed, Aug 9, 2:05 PM ET, during the session. Not investment advice.